Multi-product facilities offer valuable flexibility, but they also introduce an important question: How can you demonstrate that one product or process will not compromise another?
Meeting regulatory expectations requires more than an effective cleaning procedure. It requires a contamination control strategy that considers product hazards, facility and equipment design, personnel and material flows, cleaning validation, ongoing monitoring, and change control.
In our latest article, we explore how pharmaceutical and biotechnology companies can identify contamination pathways, establish scientifically justified controls, and determine when shared operations may no longer be appropriate.
Read the full article here to learn how to build a contamination control strategy that protects product quality, supports patient safety, and stands up to regulatory scrutiny.
